Aktis Oncology, Inc. (AKTS)
AKTS price $16.39 -0.03 -0.18%
- Ticker
- AKTS
- Price
- $16.39
- Change
- -0.03 -0.18%
- Market cap
- $880.91M
- P/E
- -15.64
- Sector
- Healthcare
- Industry
- Biotechnology
- Stocklytics score
- 65
Aktis Oncology, Inc. is a clinical-stage biotechnology firm dedicated to advancing targeted radiopharmaceutical therapies for cancer treatment. Their core innovation lies in a proprietary miniprotein radioconjugate platform, which enables the discovery and development of potent radiopharmaceutical therapies designed to precisely deliver tumor-killing radioisotopes. Among their pipeline candidates is Nectin-4, a…